Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Leukemia, Myeloid, Acute 4Leukemia, Biphenotypic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Ganglioneuroblastoma 3Burkitt Lymphoma 3Squamous Intraepithelial Lesions 2Squamous Cell Carcinoma of Head and Neck 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Head and Neck Neoplasms 2HIV Infections 2Breast Neoplasms 2Anus Neoplasms 2Wilms Tumor 1Teratoma 1Sarcoma, Synovial 1Sarcoma, Kaposi 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdomyosarcoma, Alveolar 1Prostatic Neoplasms 1Precancerous Conditions 1Papillomavirus Infections 1

Interventions

Vincristine 2Radiotherapy 2Radiation 2Magnetic Resonance Spectroscopy 2Dactinomycin 2Cyclophosphamide 2Biopsy 2X-Rays 1Vinorelbine 1Specimen Handling 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Rhabdomyosarcoma, Embryonal × Biopsy × Clear all
NCT04994132 2026-05-05

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Active not recruiting
118 enrolled
Sarcoma

Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

NCT05304585 2026-05-05

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Recruiting
205 enrolled
Sarcoma

Rhabdomyosarcoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡